385
Participants
Start Date
August 16, 2022
Primary Completion Date
August 25, 2025
Study Completion Date
December 29, 2025
Brodalumab
Brodalumab is an anti-IL-17 receptor antibody, which blocks the inflammatory effects of IL-17 in the skin.
LEO Pharma Investigational Site, Brussels
LEO Pharma Investigational Site, Leuven
LEO Pharma Investigational Site, Debrecen
LEO Pharma Investigational Site, Szolnok
LEO Pharma Investigational Site, Orosháza
LEO Pharma Investigational Site, Ham-sur-Heure-Nalinnes
LEO Pharma Investigational Site, Veszprém
LEO Pharma Investigational Site, Berlin
LEO Pharma Investigational Site, Valence
LEO Pharma Investigational Site, Santiago de Compostela
LEO Pharma Investigational Site, Athens
LEO Pharma Investigational Site, Granada
LEO Pharma Investigational Site, Rozzano
LEO Pharma Investigational Site, Hamburg
LEO Pharma Investigational Site, Kiel
LEO Pharma Investigational Site, Brescia
LEO Pharma Investigational Site, Oldenburg
LEO Pharma Investigational Site, Pavia
LEO Pharma Investigational Site, Pozuelo de Alarcón
LEO Pharma Investigational Site, Toulouse
LEO Pharma Investigational Site, Bielefeld
LEO Pharma Investigational Site, Pontevedra
LEO Pharma Investigational Site, Bologna
LEO Pharma Investigational Site, Modena
LEO Pharma Investigational Site, Saint-Priest-en-Jarez
LEO Pharma Investigational Site, Parma
LEO Pharma Investigational Site, Valencia
LEO Pharma Investigational Site, Manises
LEO Pharma Investigational Site, Münster
LEO Pharma Investigational Site, Bad Bentheim
LEO Pharma Investigational Site, Osnabrück
LEO Pharma Investigational Site, Lohne
LEO Pharma Investigational Site, Thessaloniki
LEO Pharma Investigational Site, Mainz
LEO Pharma Investigational Site, Limburg an der Lahn
LEO Pharma Investigational Site, Thessaloniki
LEO Pharma Investigational Site, Ancona
LEO Pharma Investigational Site, Wiesbaden
LEO Pharma Investigational Site, Coppito
LEO Pharma Investigational Site, Amiens
LEO Pharma Investigational Site, Napoli
LEO Pharma Investigational Site, Memmingen
LEO Pharma Investigational Site, Langenau
LEO Pharma Investigational Site, Liège
LEO Pharma Investigational Site, Kutná Hora
LEO Pharma Investigational Site, Nový Jičín
LEO Pharma Investigational Site, Plzen-Bory
LEO Pharma Investigational Site, Heraklion
LEO Pharma Investigational Site, Athens
LEO Pharma Investigational Site, Piraeus
LEO Pharma Investigational Site, Thessaloniki
LEO Pharma Investigational Site, Roma
LEO Pharma Investigational Site, Roma
LEO Pharma Investigational Site, Beek
LEO Pharma Investigational Site, Iwonicz-Zdrój
LEO Pharma Investigational Site, Lodz
LEO Pharma Investigational Site, Lodz
LEO Pharma Investigational Site, Lublin
LEO Pharma Investigational Site, Lublin
LEO Pharma Investigational Site, Poznan
LEO Pharma Investigational Site, Skierniewice
LEO Pharma Investigational Site, Warsaw
LEO Pharma Investigational Site, Warsaw
LEO Pharma Investigational Site, Warsaw
LEO Pharma Investigational Site, Wroclaw
LEO Pharma Investigational Site, Wroclaw
LEO Pharma Investigational Site, Wroclaw
LEO Pharma Investigational Site, Barcelona
LEO Pharma Investigational Site, Alicante
LEO Pharma Investigational Site, Badalona
LEO Pharma Investigational Site, Barcelona
LEO Pharma Investigational Site, Villajoyosa
LEO Pharma Investigational Site, Chorley
LEO Pharma Investigational Site, Corby
LEO Pharma Investigational Site, Corby
LEO Pharma Investigational Site, Coventry
LEO Pharma Investigational Site, Liverpool
LEO Pharma Investigational Site, London
LEO Pharma Investigational Site, London
LEO Pharma Investigational Site, Northwood
LEO Pharma Investigational Site, Shipley
Lead Sponsor
LEO Pharma
INDUSTRY